Holen Sie sich die Stockscreener-App
1.54
0.00%
0.00
Handel nachbörslich:
1.54
Schlusskurs vom Vortag:
$1.54
Offen:
$1.56
24-Stunden-Volumen:
2.07M
Relative Volume:
1.15
Marktkapitalisierung:
$592.23M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.6211
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
+21.26%
1M Leistung:
+6.94%
6M Leistung:
+13.24%
1J Leistung:
-12.00%
1-Tages-Spanne:
$1.515
$1.60
1-Wochen-Bereich:
$1.235
$1.60
52-Wochen-Spanne:
$0.92
$2.14
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.54 | 592.23M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Will Standard BioTools Inc. stock benefit from green energy trendsPortfolio Risk Report & Reliable Intraday Trade Alerts - ulpravda.ru
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - Sahm
Can Standard BioTools Inc. stock maintain operating marginsLayoff News & Expert-Curated Trade Recommendations - ulpravda.ru
Will Standard BioTools Inc. (FLB) stock rise with strong economyJuly 2025 Catalysts & Low Risk High Reward Ideas - ulpravda.ru
Standard BioTools Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2025 - MarketScreener
Standard BioTools Reports Preliminary Q4, Full-Year Revenue - Nasdaq
Standard BioTools (NASDAQ:LAB) & Hinge Health (NYSE:HNGE) Critical Contrast - Defense World
What analysts say about Standard BioTools Inc stockExit Strategy Tips & Investment Portfolio Recommendations - earlytimes.in
User | theeveningleader.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - markets.financialcontent.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 80% - simplywall.st
Standard BioTools: Outlook Still Murky (NASDAQ:LAB) - Seeking Alpha
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% – Here’s Why - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1%What's Next? - MarketBeat
What Standard BioTools Inc.'s (NASDAQ:LAB) 28% Share Price Gain Is Not Telling You - 富途牛牛
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9% – What’s Next? - Defense World
Can Standard BioTools Inc. stock sustain market leadershipWeekly Profit Summary & Detailed Earnings Play Alerts - Улправда
Is Standard BioTools Inc. stock a buy before product launchesQuarterly Portfolio Report & AI Powered Trade Plan Recommendations - bolumsonucanavari.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9%Time to Sell? - MarketBeat
Is Standard BioTools Inc. stock a top pick in earnings seasonIndex Update & Reliable Intraday Trade Alerts - Bölüm Sonu Canavarı
Is Standard BioTools Inc. (FLB) stock bottoming after sell offWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
Will Standard BioTools Inc. stock outperform growth indexesBreakout Watch & Expert Verified Movement Alerts - Улправда
Is Standard BioTools Inc. stock a safe investment in uncertain markets2025 Buyback Activity & Safe Entry Zone Tips - ulpravda.ru
Analysts Set Standard BioTools Inc. (NASDAQ:LAB) Price Target at $1.35 - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Zacks Research - MarketBeat
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - setenews.com
Should investors be concerned about Standard BioTools Inc (LAB)? - uspostnews.com
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 75,000 Shares - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Purchases 125,000 Shares of Stock - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Acquires 150,000 Shares of Stock - MarketBeat
Standard BioTools Inc. Stock (LAB) Opinions on Insider Purchases - Quiver Quantitative
Subdued Growth No Barrier To Standard BioTools Inc. (NASDAQ:LAB) With Shares Advancing 26% - simplywall.st
Will Standard BioTools Inc. stock attract ESG investorsQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
Why Standard BioTools Inc. (FLB) stock is upgraded to buy2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Casdin funds buy Standard Biotools (LAB) shares for $502,570 By Investing.com - Investing.com Australia
Casdin funds buy Standard Biotools (LAB) shares for $502,570 - Investing.com
Casdin Capital, LLC Increases Stake in Standard BioTools Inc - GuruFocus
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - MSN
Why Standard BioTools Inc. (FLB) stock is trending on social mediaEarnings Risk Summary & Free High Return Stock Watch Alerts - Newser
How Standard BioTools Inc. (FLB) stock trades in high volatility2025 Market Sentiment & Daily Price Action Insights - Newser
Why analysts raise outlook for Standard BioTools Inc. (FLB) stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Weekly Trades: Will Standard BioTools Inc stock attract ESG investorsJuly 2025 Price Swings & AI Driven Stock Movement Reports - BỘ NỘI VỤ
Published on: 2025-12-01 23:56:21 - Newser
BioTools Inc.: A Deep Dive (NASDAQ:LAB) - Seeking Alpha
Penny Stocks To Watch In December 2025 - simplywall.st
Standard BioTools (NASDAQ:LAB) Director Acquires $214,500.00 in Stock - MarketBeat
Casdin Partners Master Fund, L Buys 7,550,000 Shares of Standard BioTools (NASDAQ:LAB) Stock - MarketBeat
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen - MSN
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Standard Biotools Inc-Aktie (LAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | Director |
Dec 02 '25 |
Buy |
1.42 |
125,000 |
177,512 |
71,875,000 |
| Casdin Partners Master Fund, L | Director |
Dec 03 '25 |
Buy |
1.44 |
75,000 |
108,037 |
71,950,000 |
| Casdin Partners Master Fund, L | Director |
Nov 25 '25 |
Buy |
1.30 |
7,550,000 |
9,838,405 |
71,750,000 |
| Casdin Partners Master Fund, L | Director |
Nov 24 '25 |
Buy |
1.43 |
150,000 |
214,875 |
64,200,000 |
| Casdin Partners Master Fund, L | Director |
Nov 20 '25 |
Buy |
1.30 |
450,000 |
586,260 |
64,050,000 |
| Casdin Partners Master Fund, L | Director |
Nov 19 '25 |
Buy |
1.28 |
350,000 |
448,910 |
63,600,000 |
| Casdin Partners Master Fund, L | Director |
Nov 18 '25 |
Buy |
1.23 |
275,000 |
339,405 |
63,250,000 |
| Casdin Partners Master Fund, L | Director |
Nov 13 '25 |
Buy |
1.20 |
450,000 |
541,395 |
62,500,000 |
| Casdin Partners Master Fund, L | Director |
Nov 14 '25 |
Buy |
1.24 |
250,000 |
309,800 |
62,750,000 |
| Casdin Partners Master Fund, L | Director |
Nov 17 '25 |
Buy |
1.22 |
225,000 |
275,580 |
62,975,000 |
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):